$46.60 -0.13 (%) Sanofi Shs Sponsored American Deposit Receipt Repr 1/2 Sh - NYSE

Jan. 27, 2015 | 04:00 PM

Partner Headlines

  1. US Stock Futures Signal Lower Start On Wall Street

    Benzinga | Jan. 26, 2015 | 07:14AM EST
  2. Making Money With Charles Payne: 01/19/15

    FoxBusiness | Jan. 19, 2015 | 18:00PM EST
  3. 10 Biotech Stories You Might've Missed This Week

    Benzinga | Jan. 15, 2015 | 13:18PM EST
  4. Express Scripts Eyes New Price War: Anti-PCSK9 Drugs

    IBD | Jan. 13, 2015 | 19:06PM EST
  5. Cholesterol Drug Costs Eyed

    IBD | Jan. 13, 2015 | 18:51PM EST
  6. Griffin Securities Analyst Thinks New MannKind Management Will Focus On R&D, Not Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  7. Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger

    Benzinga | Jan. 12, 2015 | 15:44PM EST
  8. Guru Stocks at 52-Week Lows: GOOG, VZ, HSBC, SNY, TOT

    GuruFocus | Jan. 12, 2015 | 10:35AM EST
  9. Regeneron rises on drug data

    IBD | Jan. 9, 2015 | 18:42PM EST
  10. Regeneron Jumps On Favorable Cholesterol Drug Report

    IBD | Jan. 9, 2015 | 15:42PM EST
  11. Indexes Slump As Employment Data, Falling Oil Weigh

    IBD | Jan. 9, 2015 | 15:13PM EST
  12. Stocks Stay In Red; Acuity Soars On Strong LED Demand

    IBD | Jan. 9, 2015 | 13:29PM EST
  13. Stocks Reverse Lower On Good News/Bad News Job Data

    IBD | Jan. 9, 2015 | 11:52AM EST
  14. Drugs May Be Blockbusters

    IBD | Jan. 8, 2015 | 18:54PM EST
  15. 5 Potential Blockbuster Drugs Set To Launch In 2015

    IBD | Jan. 8, 2015 | 08:02AM EST
  16. SHAREHOLDER ALERT: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against Sanofi ...

    GuruFocus | Jan. 2, 2015 | 15:02PM EST
  17. Guru Stocks at 52-Week Lows: HSBC, SNY, WBK, DCM, BBVA

    GuruFocus | Dec. 23, 2014 | 10:57AM EST
  18. Sanofi Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent (Influenza Vaccine) for Adults

    Benzinga | Dec. 12, 2014 | 08:04AM EST
  19. Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO

    Benzinga | Dec. 9, 2014 | 15:02PM EST
  20. Two Gauges That Point To Fund Buying In A Stock

    IBD | Dec. 8, 2014 | 18:18PM EST
  21. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  22. Mid-Day Market Update: ON Semiconductor Surges On $1 Billion Buyback Plan; POZEN Shares Slip

    Benzinga | Dec. 1, 2014 | 13:43PM EST
  23. Mid-Morning Market Update: Markets Open Lower; Weatherford To Sell Engineered Chemistry, Drilling Fluid Operations to Berkshire's Lubrizol

    Benzinga | Dec. 1, 2014 | 10:23AM EST
  24. Morning Market Losers

    Benzinga | Dec. 1, 2014 | 09:53AM EST
  25. Pharma drugs advance in EU

    IBD | Nov. 21, 2014 | 18:19PM EST
  26. AbbVie, Celgene, Sanofi Drugs Get EU Endorsements

    IBD | Nov. 21, 2014 | 12:28PM EST
  27. Sanofi's Bullish Pipeline Forecast Underwhelms Street

    IBD | Nov. 20, 2014 | 11:44AM EST
  28. Asthma treatment passes trial

    IBD | Nov. 11, 2014 | 18:30PM EST
  29. Guru Stocks at 52-Week Lows: IBM, SNY, SAN, RIO, E

    GuruFocus | Nov. 9, 2014 | 01:58AM EST
  30. Guru Stocks at 52-Week Lows: IBM, BBL, SNY, SAN, RIO

    GuruFocus | Nov. 4, 2014 | 14:23PM EST
  31. Benzinga's M&A Chatter for Thursday October 30, 2014

    Benzinga | Oct. 30, 2014 | 21:24PM EST
  32. CNBC's Stock Pops & Drops From October 29

    Benzinga | Oct. 29, 2014 | 20:29PM EST
  33. Sanofi fires CEO, downgraded

    IBD | Oct. 29, 2014 | 18:41PM EST
  34. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD | Oct. 29, 2014 | 12:51PM EST
  35. Deutsche Bank Downgrades Sanofi SA

    Benzinga | Oct. 29, 2014 | 12:29PM EST
  36. Mid-Morning Market Update: Markets Mixed; Goodyear Earnings Beat Estimates

    Benzinga | Oct. 29, 2014 | 10:43AM EST
  37. Sanofi Warns Of Flat Growth

    IBD | Oct. 28, 2014 | 18:46PM EST
  38. Markets Continue To Rally As The Dow Closes Above 17,000

    Benzinga | Oct. 28, 2014 | 16:44PM EST
  39. Mid-Afternoon Market Update: Dow Rises Over 150 Points; Kohl's Shares Decline On Weak Forecast

    Benzinga | Oct. 28, 2014 | 15:39PM EST
  40. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD | Oct. 28, 2014 | 14:42PM EST
  41. Mid-Day Market Update: Integrated Device Technology Jumps On Upbeat Earnings; Twitter Shares Decline

    Benzinga | Oct. 28, 2014 | 13:50PM EST
  42. Midday Losers From October 28: Twitter, Kohl's, Amkor Technologies And More

    Benzinga | Oct. 28, 2014 | 13:27PM EST
  43. Mid-Morning Market Update: Markets Open Higher; Pfizer Profit Tops Street View

    Benzinga | Oct. 28, 2014 | 11:06AM EST
  44. Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker

    Benzinga | Oct. 20, 2014 | 20:15PM EST
  45. Benzinga's M&A Chatter for Monday October 20, 2014

    Benzinga | Oct. 20, 2014 | 19:27PM EST
  46. Illumina Helps Make Gene Sequencing Affordable

    IBD | Oct. 17, 2014 | 18:48PM EST
  47. Regeneron's Eylea Tops Rivals

    IBD | Oct. 17, 2014 | 18:45PM EST
  48. Regeneron Eye Drug Beats Rivals While Amgen Sues

    IBD | Oct. 17, 2014 | 11:27AM EST
  49. Alnylam jumps on trial results

    IBD | Oct. 13, 2014 | 18:46PM EST
  50. Alnylam Drug Scores Against Rare Nerve Disease

    IBD | Oct. 13, 2014 | 13:59PM EST
Trading Center